ICON plc

ICLRintermediary

ICON is the world's second-largest CRO (contract research organization), managing clinical trials for pharma and biotech companies globally. CROs like ICON benefit from biopharma R&D outsourcing trends.

⇄ Compare

Produk & Pendapatan

Pangsa Pendapatan Produk

Komposisi Pendapatan ($8.3B)

Data statis (memuat keuangan langsung…)

Clinical Research Services (100%)

Komposisi segmen dan pelanggan utama

Detail produk

Clinical Development Services75%

Phase I-IV clinical trials, data management, biostatistics — full-service CRO.

PRA Health Sciences (Legacy)25%

Acquired PRA 2021 — integrated services doubling ICON's scale.

Hubungan Rantai Pasok

Pelanggan Utama

Pfizer Inc.

Clinical trial services

Dampak: large

Eli Lilly and Company

Clinical trial services

Dampak: growing

Konteks makro dan pasar

헬스케어Berita sektor

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Katalis mendatang

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Berita terkini

Memuat berita...

Analisis AI

Klik "Dapatkan Analisis AI" untuk analisis rantai pasok ICON plc.

Info Perusahaan

Kantor Pusat

Dublin, Ireland

Didirikan

1990

Karyawan

40,000

Situs Web

iconplc.com

Gambaran umum sektor — 헬스케어

Berita sektor